New Analysis: “[Drug pricing] plans could be put on hold in the near-term, if…PhRMA can craft a narrative that makes lawmakers and President Trump unwilling to challenge drugmakers” HEADLINE:…
Read moreBrett Giroir Tapped Despite Questionable Record and Judgment WASHINGTON, D.C. – Today Accountable.US criticized President Trump’s Health and Human Services Department for naming Brett Giroir as deputy of the department’s coronavirus/COVID-19…
Read moreREAD: Full text of the Freedom of Information Act request Washington, DC – Today, Patients Over Pharma sent a Freedom of Information Act request to the Department…
Read moreSecretary Azar refused to guarantee coronavirus vaccine/treatment affordability: “…we can’t control that price, because we need the private sector to invest…Price controls won’t get us there” Washington, DC – Today, Patients…
Read more(Washington, DC) – With Secretary Alex Azar preparing to testify in front of the House and Senate this week on his overall budget request as well as the Administration’s response to the coronavirus outbreak,…
Read moreWASHINGTON, D.C. – With reports that Senator Chuck Grassley (R-IA), Chairman of the Senate Finance Committee, is hoping to meet with Speaker Pelosi to begin negotiations over drug pricing legislation, …
Read moreSenator Grassley: “We got 23 Republicans up for re-election. And it’s an issue in every state and it’s an issue nationally. So, I’ve got the game in town that you…
Read moreBigPharmasBestFriends.org reveals at least 60 pharmaceutical companies and lobbying groups represented in the Trump administration Washington, D.C. – Today, Patients Over Pharma released an updated and…
Read moreMORNING OF SPEECH: “INSULIN PRICES IN THE SPOTLIGHT AT STATE OF THE UNION — President Donald Trump is expected to announce a new initiative to lower the cost of insulin…
Read moreWASHINGTON, D.C. – In advance of President Trump’s State of the Union Address, Patients Over Pharma released the following statement and background research highlighting his long record of broken…
Read moreNew letter from conservative groups opposing progress on prescription drug costs comes as new poll shows issue is top priority for people, Trump at 54% disapproval on…
Read moreWASHINGTON, D.C. – As some of the biggest and most profitable pharmaceutical companies prepare to announce their fourth-quarter earnings over the coming weeks, Patients Over Pharma released the following statement…
Read more